The House of Lords Clarifies “Biogen Insufficiency”

Authors

  • Eddy D. Ventose * Attorney-at-Law

DOI:

https://doi.org/10.2966/scrip.060309.718

Abstract

The author considers the recent House of Lords’ jurisprudence on “Biogen insufficiency”, arising from its 1997 decision in Biogen Inc v Medeva Plc, which holds that unless claims in the patent specification correspond to the teachings of the patent, the patent will be invalid.

Downloads

Published

01-Dec-2009

Issue

Vol. 6 No. 3 (2009): Volume 6

Section

Analysis